Zenotech Laboratories Limited
BSE: ZENOTECH.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Sachin Laxmanappa Gavandare
- Employees
- 208
- Headquarters
- Hyderabad, India
- IPO year
- 2004
- Market cap
- ₹2.9B
- Website
- http://www.zenotechlab.com
Loading ZENOTECH…
Loading profile data…Frequently asked questions about ZENOTECH
What does Zenotech Laboratories Limited (ZENOTECH.BO) do?
Zenotech Laboratories Ltd. engages in the manufacture and marketing of pharmaceuticals products. The firm involves in the production of granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). Its injectable product portfolio serves niche therapy areas like oncology and anesthesiology. The compan...
Where does ZENOTECH.BO trade?
Zenotech Laboratories Limited (ZENOTECH.BO) trades on the Bombay Stock Exchange.
What sector is ZENOTECH.BO in?
Zenotech Laboratories Limited (ZENOTECH.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Zenotech Laboratories Limited?
Sachin Laxmanappa Gavandare is the chief executive officer of Zenotech Laboratories Limited (ZENOTECH.BO).
Where is Zenotech Laboratories Limited headquartered?
Zenotech Laboratories Limited is headquartered in India.
Does ZENOTECH.BO pay a dividend?
Zenotech Laboratories Limited (ZENOTECH.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ZENOTECH.BO go public?
Zenotech Laboratories Limited (ZENOTECH.BO) completed its initial public offering in 2004.